DHA
Best-in-class: Advanced DHA
A concentrated, high-DHA omega-3 — the specific fatty acid that dominates brain, retina and nervous-tissue membranes (where EPA is more anti-inflammatory, DHA is more structural/neural).
DHA quick facts
| Suggested dose | 1–2 g DHA daily with food. |
| How often | daily |
| Who it's for | Brain, eye, pregnancy and cognitive-aging support. |
The right choice when the target is brain, eye or pregnancy rather than triglycerides or cardiovascular events — for those, EPA-predominant formulations have the better data, and that difference explains a lot of the apparently contradictory omega-3 trial literature. DHA is the one that accumulates in fetal brain tissue in the third trimester. Algal DHA is a legitimate vegan route and is where the fish get it from anyway.
How DHA actually works
DHA is a structural fatty acid rather than primarily a signaling one — it makes up a large fraction of the phospholipid in neuronal membranes and in the photoreceptor discs of the retina, where its extreme flexibility allows the conformational changes rhodopsin and membrane receptors require. It is also the substrate for the D-series resolvins and protectins that actively terminate neuroinflammation. EPA and DHA have genuinely different jobs, which is why the ratio matters.
Where to get DHA
Buy Advanced DHA at Thorne →The evidence for DHA
Graded by what exists behind each claim.
✅ Clinically validated
- DHA supports fetal/infant brain and eye development (well-established; a prenatal staple).
- Higher DHA status is linked to better cognitive aging in RCT and cohort data.
📊 Correlative data
- Low DHA/omega-3 index tracks with faster cognitive decline and mood issues.
🧪 Theoretical / extrapolated benefits
- Neuroprotective and longevity roles from membrane fluidity and resolvin production are promising but still translating to outcomes.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What DHA actually does
Docosahexaenoic acid is not a nutrient the body uses and excretes. It is a building material that gets installed, and the installation is slow. It is a 22-carbon fatty acid with six cis double bonds, and that geometry is the point: the kinked chain will not pack tightly, so a membrane rich in it is more fluid and more deformable. It concentrates in the phospholipids of retinal outer segments and synaptic membranes, where that flexibility supports conformational changes in embedded proteins.
The relevant pool is a membrane pool, so the relevant clock is membrane turnover. Plasma concentration after a capsule tells you about transport, not about installation. The measurement that reflects the pool is the erythrocyte fatty acid composition, and work on the influence of fish consumption and supplementation on the omega-3 index of young adults exists because that index is the readout of the slow compartment McMullan 2025.
Membrane synthesis is co-limited, which is the mechanistic detail almost nobody states. Building a phospholipid requires a fatty acid and a head group. Gerbil work showed that giving uridine alongside docosahexaenoic acid increased synaptic proteins and phospholipids in brain beyond the fatty acid alone Wurtman 2006, and a companion study reported increased dendritic spine density with the combination Sakamoto 2007. The fatty acid is one substrate in a two-substrate reaction.
Which is why endogenous synthesis is not a substitute. Conversion of alpha-linolenic acid through to docosahexaenoic acid was measured with labeled tracer in young women and found to occur, at a low fractional rate Burdge 2002. A plant-oil capsule and a fish oil capsule are not interchangeable inputs to the same membrane.
Cell, rodent, human — and where it stops
The trials that matter here are the ones that ran long enough, and several famous ones did not.
What has been measured in people. A randomized trial of docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease reported its primary endpoints Quinn 2010. A randomized trial of docosahexaenoic acid during pregnancy examined maternal depression and child neurodevelopment Makrides 2010. A randomized study measured the effect of docosahexaenoic acid on a biomarker of head trauma in American football players Oliver 2016. And the omega-3 index literature describes how fish consumption and supplementation move the membrane measure itself McMullan 2025.
The first obstacle is that the endpoint clock and the incorporation clock are different lengths. Erythrocyte content shifts over months McMullan 2025, and a trial that randomizes a capsule and measures a clinical outcome at 12 weeks has spent most of its duration filling the compartment rather than testing it.
The second obstacle is baseline. The effect of adding docosahexaenoic acid depends on how much is already installed, and a trial that does not measure the omega-3 index at entry has randomized a dose into an unmeasured starting position McMullan 2025. That is a large part of why trials in different countries with different fish intakes disagree.
The third obstacle is that the rodent mechanism used two substrates and the human trials used one. The gerbil work is a uridine-plus-docosahexaenoic-acid result Wurtman 2006 Sakamoto 2007. Human cognitive trials generally gave the fatty acid alone Quinn 2010, which is a different experiment from the one the mechanism papers describe.
What would close the gap. Enroll by omega-3 index rather than by self-reported intake, run for at least six months, and report the index at every visit so the exposure achieved is visible next to the outcome.
DHA — which form, and does it matter
Triglyceride, ethyl ester and phospholipid-bound are three chemistries and they are absorbed at different rates. Natural fish oil is triglyceride-bound; concentration to high-potency products usually proceeds through an ethyl ester, which pancreatic lipase hydrolyzes more slowly, and re-esterified triglyceride is the step back. The consequence is a difference in how quickly the omega-3 index responds rather than whether it responds McMullan 2025.
Ethyl esters are the reason the with-food instruction is not optional. Hydrolysis of an ethyl ester depends on lipase activity and bile, both of which follow a fatty meal. A high-potency capsule taken with black coffee is being asked to be absorbed without the conditions its chemistry requires.
Docosahexaenoic acid and eicosapentaenoic acid are not interchangeable and the ratio is the specification. A DHA-dominant product is the one relevant to the neural and retinal claims Quinn 2010 Makrides 2010; an EPA-dominant product belongs to a different literature. The number on the front of the bottle is often the total oil weight rather than the combined DHA and EPA, and those two numbers can differ by a factor of three.
Alpha-linolenic acid is not a form of this. Tracer work quantified the conversion and found it small Burdge 2002. A flax capsule is a different input. No filed panel for the vendor docosahexaenoic acid product on this site has been read into supplements_data.BLENDS, so this page states no per-capsule DHA or EPA content for it.
What would have to be true, and how you would know it was not
1. The incorporation prediction, and it is the clock test. Omega-3 index at baseline, 3 months and 6 months. Predict a substantial rise by 3 months and a plateau approaching 6, because the erythrocyte compartment turns over slowly McMullan 2025. Anyone measuring at 4 weeks and concluding nothing happened has measured early.
2. The with-food prediction. Same product, 8 weeks taken with the largest meal of the day and 8 weeks taken fasted, index measured at each end. Predict the with-food block moves the index further, especially for an ethyl ester product.
3. The cognitive prediction, deliberately unflattering. In an adult with established cognitive decline, predict no meaningful change on a validated battery at 6 months, because that is what the randomized trial in Alzheimer disease found Quinn 2010. Buying this to reverse an existing decline is buying past the evidence.
4. The head-group prediction, which nobody has run in people. Predict that adding uridine monophosphate to docosahexaenoic acid does more for a membrane-dependent endpoint than the fatty acid alone, which is the rodent result Wurtman 2006 Sakamoto 2007. If a human trial found no difference, the two-substrate account would be wrong for people.
5. The conversion prediction. Give alpha-linolenic acid at a matched gram dose for 12 weeks and measure the index. Predict a much smaller rise than from preformed docosahexaenoic acid, which is what the tracer work implies Burdge 2002.
What nobody has tested yet
Nobody has enrolled a cognitive trial by omega-3 index. The index is measurable McMullan 2025 and the major trials randomized by capsule Quinn 2010, which leaves baseline status uncontrolled in the studies people cite most.
Nobody has replicated the uridine combination in adults. The co-substrate mechanism is a rodent finding Wurtman 2006 Sakamoto 2007 with no adult human counterpart at that design.
Nobody knows the right maintenance interval. Because the membrane pool is slow, weekly or thrice-weekly dosing might maintain an index as well as daily dosing does, and no trial has compared them.
And the head-trauma biomarker signal has not been taken forward. A change in a blood biomarker in football players Oliver 2016 is not a change in injury outcome, and the trial that would connect them has not been run.
DHA — its own safety story, not its category's
The effect that belongs to this molecule rather than to fish oil generally is a mild, dose-dependent lengthening of bleeding time, and the practical rule is a schedule around procedures. The mechanism is incorporation into platelet membranes and a shift in eicosanoid production, which means it takes weeks to establish and weeks to reverse -- so stopping the day before surgery does very little McMullan 2025.
Additive with antiplatelets and anticoagulants. The interaction is pharmacodynamic and does not change drug levels, so it will not be visible as an altered assay. Anyone on warfarin, apixaban, rivaroxaban, clopidogrel or aspirin should tell their prescriber this is in the cupboard.
Oxidation is a product-quality risk that is easy to detect and widely ignored. Highly unsaturated oils go rancid; six double bonds is the most oxidizable configuration in the category. A fishy burp or a rancid smell means the oil has degraded, and the degradation products are not inert. Refrigeration and a peroxide-value specification are the answers.
Pregnancy is the one place the trials are unusually informative. A large randomized trial gave it during pregnancy and reported maternal and child outcomes Makrides 2010, which is a better evidence base than most supplements have in that population and still a reason to make the decision with the clinician providing antenatal care. Nothing here is medical advice or a diagnosis, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Quinn JF. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010 · PMID 21045096
- Makrides M, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children. JAMA 2010 · PMID 20959577
- Oliver JM, Jones MT, et al. Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football. Medicine and Science in Sports and Exercise 2016 · PMID 26765633
- Burdge GC, et al. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.. British Journal of Nutrition 2002 · PMID 12323090
- McMullan JE. Influence of fish consumption and omega-3 supplementation on the omega-3 index of young adults: a 2x2 factorial randomised control trial (YouFish Study). J Nutr 2025 · PMID 41082976
- Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Research 2007 · PMID 17950710
- Wurtman RJ, Ulus IH, et al. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Research 2006 · PMID 16631143
How you would know if it worked
The APOE page on this site prescribes this product by name and adds the condition that matters — the evidence is stronger when DHA is started early rather than after cognitive decline has begun. That makes genotype the first test rather than an afterthought, and it is the rare one you run once: APOE is fixed for life, so a single draw tells you whether you are in the group with the most to gain from starting now. It also tells you something you may not want to know, which is a fair reason to think before ordering it. The lipid panel is the second because a concentrated fatty acid at 1,000-2,000 mg a day does move triglycerides. Draw them before you start and again at 12 weeks. What no test here settles is the claim DHA is actually bought for: brain and retinal membrane composition is not a blood draw, and the omega-3 index that comes closest is not on this menu.
- APOE Genotyping Retest: Never — it's fixed for life.
- Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) Retest: Every 3–6 months on androgens; annually otherwise.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
DHA — safety & side effects
- Fishy burps; otherwise well tolerated.
- Raises LDL cholesterol more than EPA does — a real, reproducible difference worth knowing if you are managing lipids.
- Mild antiplatelet effect at high doses. Algal DHA is the vegetarian source and is equivalent.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — DHA in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside DHA
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Triglycerides are what omega-3 moves most reliably |
| ApoB (Apolipoprotein B) | Whether the particle count moved, not just the cholesterol number |
| hs-CRP (High-Sensitivity C-Reactive Protein) | The anti-inflammatory claim, measured |
The Real Cardiovascular Risk panel covers these in one order — 9 markers, $187.60 with the discount applied.
Check results you already have → · All 103 markers A–Z
DHA — frequently asked questions
What is DHA?
A concentrated, high-DHA omega-3 — the specific fatty acid that dominates brain, retina and nervous-tissue membranes (where EPA is more anti-inflammatory, DHA is more structural/neural).
What is the suggested dose of DHA?
1–2 g DHA daily with food. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find DHA dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy DHA?
Coach Cam sources DHA from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
What DHA is used for
DHA appears under 1 goal in the goal router.
Related Omega & Fats supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.